ALDEYRA THERAPEUTICS, INC.

Analyst Reco. Aldeyra Therapeutics, Inc.

Equities

ALDX

US01438T1060

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-01 pm EDT			5-day change	1st Jan Change
4.2 ^USD	+6.60%		+6.60%	+19.66%

Apr. 25	Transcript : Aldeyra Therapeutics, Inc. - Special Call
Apr. 04	North American Morning Briefing : Focus Turns to -2-	DJ

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oppenheimer Upgrades Aldeyra Therapeutics to Outperform From Perform, $10 Price Target	Apr. 03	MT
Citigroup Adjusts Price Target on Aldeyra Therapeutics to $8 From $25, Maintains Buy Rating	23-10-17	MT
Citigroup Adjusts Aldeyra Therapeutics Price Target to $25 From $28, Maintains Buy Rating	23-06-01	MT
Berenberg Bank Terminates Coverage of 85 Companies in Consumer Discretionary, Healthcare, Industrial Tech, REIT, Software and IT Services Sectors	22-07-01	MT
Oppenheimer Adjusts Aldeyra Therapeutics Price Target to $11 From $10, Maintains Outperform Rating	22-06-09	MT
Citigroup Adjusts Aldeyra Therapeutics' Price Target to $26 From $21, Reiterates Buy Rating	22-06-09	MT
HC Wainwright Assumes Aldeyra Therapeutics at Buy with $15 Price Target	22-04-27	MT
Berenberg Bank Adjusts Aldeyra Therapeutics PT to $28 From $32, Maintains Buy Rating	21-12-22	MT
Alliance Global Partners Adjusts Aldeyra Therapeutics PT to $24 From $32, Maintains Buy Rating	21-12-21	MT
Oppenheimer Adjusts Aldeyra Therapeutics' Price Target to $10 From $16, Maintains Outperform Rating	21-12-21	MT
SVB Leerink Adjusts Aldeyra Therapeutics' Price Target to $15 From $24, Keeps Outperform Rating	21-12-21	MT
Citigroup Adjusts Aldeyra Therapeutics' Price Target to $21 From $25, Keeps Buy Rating	21-12-21	MT
Berenberg US CEO Conference	21-11-10	FA
ALDEYRA THERAPEUTICS : SVB Leerink Starts Aldeyra Therapeutics at Outperform with $22 Price Target	21-03-12	MT
ALDEYRA THERAPEUTICS : HC Wainwright Starts Aldeyra Therapeutics at Buy With $26 Price Target	21-02-08	MT
ALDEYRA THERAPEUTICS : Berenberg Bank Initiates Coverage on Aldeyra Therapeutics With Buy Rating, $32 Price Target	20-12-16	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer